Skip to main content

1 Result(s)

within Biomedicine Remove this filter Metabolic Diseases Remove this filter Momoko Ohori Remove this filter

and

  1. No Access

    Article

    Polygenic architecture informs potential vulnerability to drug-induced liver injury

    Drug-induced liver injury (DILI) is a leading cause of termination in drug development programs and removal of drugs from the market; this is partially due to the inability to identify patients who are at risk1. ...

    Masaru Koido, Eri Kawakami, Junko Fukumura, Yui Noguchi, Momoko Ohori… in Nature Medicine (2020)